Terms: = Germ cell tumor AND PHOX2B, 8929 AND Prognosis
16 results:
1. SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma.
Tan K; Mo J; Li M; Dong Y; Han Y; Sun X; Ma Y; Zhu K; Wu W; Lu L; Liu J; Zhao K; Zhang L; Tang Y; Lv Z
J Exp Clin Cancer Res; 2022 Dec; 41(1):352. PubMed ID: 36539767
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1/2.
Hsu CL; Yin CF; Chang YW; Fan YC; Lin SH; Wu YC; Huang HC; Juan HF
Cell Death Dis; 2022 Sep; 13(9):809. PubMed ID: 36130928
[TBL] [Abstract] [Full Text] [Related]
3. Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.
Przybyła W; Gjersvoll Paulsen KM; Mishra CK; Nygård S; Engebretsen S; Ruud E; Trøen G; Beiske K; Baumbusch LO
PLoS One; 2022; 17(8):e0273280. PubMed ID: 36037157
[TBL] [Abstract] [Full Text] [Related]
4. Ganglion cell maturation in peripheral neuroblastic tumours of children.
Sarnat HB; Yu W
Clin Neuropathol; 2022; 41(3):101-113. PubMed ID: 35142286
[TBL] [Abstract] [Full Text] [Related]
5. Histone deacetylase HDAC2 regulates microRNA-125a expression in neuroblastoma.
Liu D; Tang X; Huang Z; Wen J; Zhou Y
Brain Behav; 2022 Feb; 12(2):e2401. PubMed ID: 35060363
[TBL] [Abstract] [Full Text] [Related]
6. The expression of phox2b in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma.
Fan H; Xing T; Hong H; Duan C; Zhao W; Zhao Q; Wang X; Huang C; Zhu S; Jin M; Su Y; Gao C; Ma X
Pediatr Hematol Oncol; 2022 May; 39(4):343-356. PubMed ID: 34752187
[TBL] [Abstract] [Full Text] [Related]
7. Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.
Druy AE; Shorikov EV; Tsaur GA; Popov AM; Zaychikov AN; Tuponogov SN; Saveliev LI; Tytgat GAM; Fechina LG
Pediatr Blood Cancer; 2018 Nov; 65(11):e27354. PubMed ID: 30007008
[TBL] [Abstract] [Full Text] [Related]
8. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and prognosis.
Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
[No Abstract] [Full Text] [Related]
9. PHOX2A and phox2b are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line.
Di Lascio S; Saba E; Belperio D; Raimondi A; Lucchetti H; Fornasari D; Benfante R
Exp Cell Res; 2016 Mar; 342(1):62-71. PubMed ID: 26902400
[TBL] [Abstract] [Full Text] [Related]
10. phox2b is a suppressor of neuroblastoma metastasis.
Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
[TBL] [Abstract] [Full Text] [Related]
11. Oncologic Phenotype of Peripheral Neuroblastic tumors Associated With phox2b Non-Polyalanine Repeat Expansion Mutations.
Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
[TBL] [Abstract] [Full Text] [Related]
12. Neuroblastoma: paradigm for precision medicine.
Irwin MS; Park JR
Pediatr Clin North Am; 2015 Feb; 62(1):225-56. PubMed ID: 25435121
[TBL] [Abstract] [Full Text] [Related]
13. New insights into the genetics of neuroblastoma.
Sridhar S; Al-Moallem B; Kamal H; Terrile M; Stallings RL
Mol Diagn Ther; 2013 Apr; 17(2):63-9. PubMed ID: 23329364
[TBL] [Abstract] [Full Text] [Related]
14. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Ichou FA; den Ouden E; Versteeg R; Caron HN; Tytgat GA; van der Schoot CE
Clin Cancer Res; 2012 Feb; 18(3):808-14. PubMed ID: 22142825
[TBL] [Abstract] [Full Text] [Related]
15. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
[TBL] [Abstract] [Full Text] [Related]
16. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors.
Corrias MV; Haupt R; Carlini B; Cappelli E; Giardino S; Tripodi G; Tonini GP; Garaventa A; Pistoia V; Pistorio A
Pediatr Blood Cancer; 2012 Jan; 58(1):43-9. PubMed ID: 21254375
[TBL] [Abstract] [Full Text] [Related]
